• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HBsAg+/HBeAg- 母亲所生未感染婴儿的乙型肝炎特异性 T 辅助细胞反应。

Hepatitis B-specific T helper cell responses in uninfected infants born to HBsAg+/HBeAg- mothers.

机构信息

Second Department of Pediatrics, Allergy Research Center, University of Athens, Athens, Greece.

出版信息

Cell Mol Immunol. 2010 Nov;7(6):454-8. doi: 10.1038/cmi.2010.34. Epub 2010 Jul 26.

DOI:10.1038/cmi.2010.34
PMID:20657604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4002954/
Abstract

Vertically transmitted hepatitis B virus (HBV) usually causes chronic infection. While combined active-passive immunoprophylaxis in neonates of hepatitis B surface antigen-positive (HBsAg(+)) mothers at birth prevents vertical transmission, it is not yet clear whether neonates encounter the virus or its products in the absence of hepatitis B e antigen (HBeAg). This study was undertaken to investigate HBV antigen-specific T-cell responses in vaccinated neonates of HBsAg(+)/HBeAg(-) mothers. Blood was collected from 46 HBsAg(+) mothers and their neonates (subjects) as well as 24 age-matched controls. All neonates of HBsAg(+) mothers received appropriate immunoprophylaxis, and HBsAg and hepatitis B surface antibody (anti-HBs) antibody titers were determined after completion of the vaccination course. Peripheral blood mononuclear cells (PBMCs) from infants at birth, 1 and 6 months of age were stimulated with recombinant HBsAg, hepatitis B core antigen (HBcAg) and mitogen, and interferon (IFN)-γ concentrations were determined by ELISA. HBsAg-induced production of IL-2, IL-5, IL-6 and IL-10 was assessed using a cytometric bead array kit on cells from 6-month-old neonates post-vaccination. All neonates were HBsAg(-) and responded to vaccination. Increased IFN-γ production following HBcAg stimulation was seen in 30.4% of neonates born to HBsAg(+)/HBeAg(-) mothers. Subjects demonstrated significantly higher IL-2 production post-HBsAg stimulation, whereas IL-5, IL-6 and IL-10 cytokine responses were not significantly different. Almost one-third of uninfected neonates developed viral antigen-induced IFN-γ production, suggesting that they had been exposed to virions or viral derivatives. This encounter, however, did not impair their T-cell responses to vaccination.

摘要

乙型肝炎病毒(HBV)垂直传播通常导致慢性感染。虽然在乙型肝炎表面抗原阳性(HBsAg(+))母亲的新生儿出生时联合主动-被动免疫预防可防止垂直传播,但在没有乙型肝炎 e 抗原(HBeAg)的情况下,新生儿是否接触到病毒或其产物尚不清楚。本研究旨在调查 HBsAg(+)/HBeAg(-)母亲的接种新生儿中乙型肝炎病毒抗原特异性 T 细胞反应。从 46 名 HBsAg(+)母亲及其新生儿(受试者)以及 24 名年龄匹配的对照中采集血液。所有 HBsAg(+)母亲的新生儿均接受了适当的免疫预防,在完成疫苗接种疗程后测定 HBsAg 和乙型肝炎表面抗体(抗-HBs)抗体滴度。在出生时、1 个月和 6 个月时,从婴儿外周血单核细胞(PBMC)中提取刺激物,用重组 HBsAg、乙型肝炎核心抗原(HBcAg)和有丝分裂原刺激,并通过 ELISA 测定干扰素(IFN)-γ浓度。在接种疫苗后 6 个月时,使用细胞因子珠阵列试剂盒评估 HBsAg 诱导的 IL-2、IL-5、IL-6 和 IL-10 的产生。所有新生儿均为 HBsAg(-)并对疫苗接种有反应。在 HBsAg(+)/HBeAg(-)母亲所生的新生儿中,有 30.4%的人在 HBcAg 刺激后 IFN-γ产生增加。与 HBcAg 刺激后相比,受试者在 HBsAg 刺激后显示出明显更高的 IL-2 产生,而 IL-5、IL-6 和 IL-10 细胞因子反应没有明显差异。近三分之一未感染的新生儿产生了病毒抗原诱导的 IFN-γ产生,这表明他们接触了病毒粒子或病毒衍生物。然而,这种接触并没有损害他们对疫苗接种的 T 细胞反应。

相似文献

1
Hepatitis B-specific T helper cell responses in uninfected infants born to HBsAg+/HBeAg- mothers.HBsAg+/HBeAg- 母亲所生未感染婴儿的乙型肝炎特异性 T 辅助细胞反应。
Cell Mol Immunol. 2010 Nov;7(6):454-8. doi: 10.1038/cmi.2010.34. Epub 2010 Jul 26.
2
Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates.股静脉血或脐带血中乙肝病毒血清学阳性标志物不应作为新生儿宫内感染的证据。
BMC Infect Dis. 2016 Aug 12;16(1):408. doi: 10.1186/s12879-016-1754-1.
3
Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates.乙肝疫苗接种与乙肝病毒标志物向新生儿的产前传播。
J Viral Hepat. 1999 Mar;6(2):135-9. doi: 10.1046/j.1365-2893.1999.00145.x.
4
Protective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failure.改进免疫接种对乙型肝炎病毒母婴传播的保护作用及与免疫预防失败相关的危险因素
Medicine (Baltimore). 2016 Aug;95(34):e4390. doi: 10.1097/MD.0000000000004390.
5
Hepatitis B vaccine alone may be enough for preventing hepatitis B virus transmission in neonates of HBsAg (+)/HBeAg (-) mothers.对于母亲为乙肝表面抗原(HBsAg)阳性/乙肝e抗原(HBeAg)阴性的新生儿,单独接种乙肝疫苗可能足以预防乙肝病毒传播。
Vaccine. 2017 Jan 3;35(1):40-45. doi: 10.1016/j.vaccine.2016.11.061. Epub 2016 Nov 25.
6
Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.乙肝免疫接种对预防乙肝病毒母婴传播及婴儿对乙肝疫苗免疫反应的影响。
Vaccine. 2014 Oct 21;32(46):6091-7. doi: 10.1016/j.vaccine.2014.08.078. Epub 2014 Sep 18.
7
Prevention of perinatal hepatitis B transmission in Haimen City, China: Results of a community public health initiative.中国海门市围产期乙型肝炎传播的预防:一项社区公共卫生倡议的结果
Vaccine. 2015 Jun 12;33(26):3010-5. doi: 10.1016/j.vaccine.2015.01.054. Epub 2015 Feb 16.
8
A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women.在 HBeAg 阳性孕妇中,HBsAg 定量对血清 HBV DNA 水平的预测价值。
Vaccine. 2012 Aug 3;30(36):5335-40. doi: 10.1016/j.vaccine.2012.06.036. Epub 2012 Jun 27.
9
Hepatitis B vaccination in children: the Taiwan experience.儿童乙肝疫苗接种:台湾经验
Pathol Biol (Paris). 2010 Aug;58(4):296-300. doi: 10.1016/j.patbio.2009.11.002. Epub 2010 Jan 29.
10
Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies.乙肝表面抗原阳性母亲及其婴儿的乙肝病毒DNA水平和HBeAg滴度的定量分析:HBeAg通过胎盘的情况及婴儿体内的衰减率
J Med Virol. 2003 Nov;71(3):360-6. doi: 10.1002/jmv.10493.

引用本文的文献

1
Is health, growth and development impaired in children who are Hepatitis B-exposed but uninfected?乙肝暴露但未感染的儿童的健康、生长和发育是否会受到损害?
PLOS Glob Public Health. 2025 Aug 19;5(8):e0004984. doi: 10.1371/journal.pgph.0004984. eCollection 2025.
2
Immunogenicity of a Birth Dose of Hepatitis B Vaccine in Kinshasa, Democratic Republic of Congo: A Randomised, Controlled Trial.刚果民主共和国金沙萨出生时乙肝疫苗免疫原性的随机对照试验。
J Viral Hepat. 2024 Dec;31(12):795-807. doi: 10.1111/jvh.14003. Epub 2024 Sep 24.
3
Effects of hepatitis B virus infection and strategies for preventing mother-to-child transmission on maternal and fetal T-cell immunity.乙型肝炎病毒感染及母婴传播阻断策略对母婴 T 细胞免疫的影响。
Front Immunol. 2023 Feb 16;14:1122048. doi: 10.3389/fimmu.2023.1122048. eCollection 2023.
4
The Protective Role of Maternal Immunization in Early Life.母体免疫在生命早期的保护作用。
Front Pediatr. 2021 Apr 28;9:638871. doi: 10.3389/fped.2021.638871. eCollection 2021.
5
Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics.乙型肝炎与妊娠:病毒学和免疫学特征
Hepatol Commun. 2020 Jan 2;4(2):157-171. doi: 10.1002/hep4.1460. eCollection 2020 Feb.
6
Presence of Precore (C)/C Promoter Mutants in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B (CHB) Carriers During Pregnancy Does Not Correlate with Increased Risk of Liver Disease in 4 Years of Follow-Up.在妊娠期间,慢性乙型肝炎(CHB)携带者外周血单个核细胞中前核心(C)/C 启动子突变的存在与 4 年随访期间肝病风险的增加无关。
Dig Dis Sci. 2020 Jan;65(1):204-214. doi: 10.1007/s10620-019-05745-w. Epub 2019 Aug 2.
7
Beyond Passive Immunity: Is There Priming of the Fetal Immune System Following Vaccination in Pregnancy and What Are the Potential Clinical Implications?超越被动免疫:孕期接种疫苗后胎儿免疫系统会被激活吗?其潜在的临床意义是什么?
Front Immunol. 2018 Jul 16;9:1548. doi: 10.3389/fimmu.2018.01548. eCollection 2018.
8
In utero development of memory T cells.在子宫内发育的记忆 T 细胞。
Semin Immunopathol. 2017 Nov;39(6):585-592. doi: 10.1007/s00281-017-0650-0. Epub 2017 Sep 12.
9
Tolerance and immunity to pathogens in early life: insights from HBV infection.早期生命中对病原体的耐受和免疫:来自乙肝病毒感染的启示。
Semin Immunopathol. 2017 Nov;39(6):643-652. doi: 10.1007/s00281-017-0641-1. Epub 2017 Jul 6.
10
Treatment of chronic hepatitis B with pattern recognition receptor agonists: Current status and potential for a cure.使用模式识别受体激动剂治疗慢性乙型肝炎:现状与治愈潜力
Antiviral Res. 2015 Sep;121:152-9. doi: 10.1016/j.antiviral.2015.07.006. Epub 2015 Jul 20.

本文引用的文献

1
Dendritic cells in uninfected infants born to hepatitis B virus-positive mothers.乙肝病毒阳性母亲所生未感染婴儿体内的树突状细胞。
Clin Vaccine Immunol. 2010 Jul;17(7):1079-85. doi: 10.1128/CVI.00074-10. Epub 2010 May 12.
2
Biological and clinical implications of HBV infection in peripheral blood mononuclear cells.乙肝病毒感染在外周血单个核细胞中的生物学及临床意义
Autoimmun Rev. 2008 Oct;8(1):13-7. doi: 10.1016/j.autrev.2008.07.016. Epub 2008 Aug 13.
3
Hepatitis B virus infection.乙型肝炎病毒感染
Semin Fetal Neonatal Med. 2007 Jun;12(3):160-7. doi: 10.1016/j.siny.2007.01.013. Epub 2007 Feb 28.
4
Dendritic cells from chronic hepatitis B patients can induce HBV antigen-specific T cell responses.慢性乙型肝炎患者的树突状细胞可诱导HBV抗原特异性T细胞反应。
World J Gastroenterol. 2004 Jun 1;10(11):1578-82. doi: 10.3748/wjg.v10.i11.1578.
5
Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adults.
Vaccine. 2004 Jan 2;22(3-4):511-9. doi: 10.1016/j.vaccine.2003.07.020.
6
Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection.探索乙肝病毒感染中乙肝e抗原的生物学基础。
Hepatology. 2003 Nov;38(5):1075-86. doi: 10.1053/jhep.2003.50453.
7
Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies.乙肝表面抗原阳性母亲及其婴儿的乙肝病毒DNA水平和HBeAg滴度的定量分析:HBeAg通过胎盘的情况及婴儿体内的衰减率
J Med Virol. 2003 Nov;71(3):360-6. doi: 10.1002/jmv.10493.
8
Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.重组乙型肝炎疫苗(安在时):对其免疫原性及预防乙型肝炎保护效力的综述
Drugs. 2003;63(10):1021-51. doi: 10.2165/00003495-200363100-00006.
9
The antibody response to HBs antigen is regulated by coordinated Th1 and Th2 cytokine production in healthy neonates.在健康新生儿中,对乙肝表面抗原的抗体反应受Th1和Th2细胞因子协同产生的调节。
Clin Exp Immunol. 2003 Mar;131(3):451-6. doi: 10.1046/j.1365-2249.2003.02093.x.
10
[Hepatitis viruses: mother to child transmission].
Pathol Biol (Paris). 2002 Nov;50(9):568-75. doi: 10.1016/s0369-8114(02)00351-6.